Literature DB >> 9152862

Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats.

J Marcil1, C Thibault, M B Anand-Srivastava.   

Abstract

In the present studies we have investigated if the increased expression of Gi alpha proteins reported earlier in heart and aorta from SHR (spontaneously hypertensive rats) is the cause or effect of hypertension. The SHRs at various ages of the development of blood pressure (3-5 days, 2 weeks, 4 weeks and 8 weeks) and their age-matched WKY were used for these studies. The expression of Gi alpha-2 and Gi alpha-3 (inhibitory guanine nucleotide regulatory protein and Gs alpha (stimulatory guanine nucleotide regulatory protein) at protein and mRNA level was determined by immunoblotting and Northern blotting technique using specific antibodies and cDNA probes. The SHR at early ages up to 2 weeks did not show any increase in blood pressure, however it started to go up from 4 weeks. The levels of Gi alpha 2 and Gi alpha 3 at protein and mRNA in heart from SHR were not different in 3-5 days old SHR as compared to WKY (Wistar-Kyoto rats), however, the expression of Gi alpha-2 and Gi alpha-3 protein and mRNA was significantly increased in 2 weeks and older SHR. The mRNA level of the catalytic subunit type V enzyme was significantly decreased in SHR 2 weeks and later ages as compared to their age-matched WKY. On the other hand, the expression of Gs alpha was not different in SHR as compared to WKY at all the ages studied. In addition, the oxotremorine and C-ANF4-23 (a ring deleted analog of atrial natriuretic factor) mediated inhibitions of adenylyl cyclase in hearts and aorta were also significantly enhanced in 2 weeks and older SHRs as compared to WKY rats, whereas, at younger age of SHR (3-5 days old), no change in the percent inhibition of adenylyl cyclase by C-ANF4-23 was observed and oxotremorine was unable to inhibit adenylyl cyclase activity. Furthermore, the basal enzyme activity and the stimulatory responses of isoproterenol, NECA (N-ethylcarboxamideadenosine), glucagon and forskolin on adenylyl cyclase were significantly decreased at all ages of SHR as compared to WKY. These results suggest that the increased expression of genes for Gi alpha-2 and Gi alpha-3, decreased expression of type V enzyme mRNA and decreased cAMP levels precedes the development of blood pressure and may participate in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152862     DOI: 10.1006/jmcc.1996.0343

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

1.  Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Authors:  Grzegorz Godlewski; Shakiru O Alapafuja; Sándor Bátkai; Spyros P Nikas; Resat Cinar; László Offertáler; Douglas Osei-Hyiaman; Jie Liu; Bani Mukhopadhyay; Judith Harvey-White; Joseph Tam; Karel Pacak; Jacqueline L Blankman; Benjamin F Cravatt; Alexandros Makriyannis; George Kunos
Journal:  Chem Biol       Date:  2010-11-24

2.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

3.  NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder.

Authors:  Molupe Lehohla; Lauriston Kellaway; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

4.  Modulation of Gi Proteins in Hypertension: Role of Angiotensin II and Oxidative Stress.

Authors:  Madhu B Anand-Srivastava
Journal:  Curr Cardiol Rev       Date:  2010-11

5.  Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).

Authors:  Su Jin Moon; Chang Ju Kim; Yeon Jung Lee; Minha Hong; Juhee Han; Geon Ho Bahn
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

6.  Knockdown of Inhibitory Guanine Nucleotide Binding Protein Giα-2 by Antisense Oligodeoxynucleotides Attenuates the Development of Hypertension and Tachycardia in Spontaneously Hypertensive Rats.

Authors:  Yousra Ali El-Basyuni; Yuan Li; Madhu B Anand-Srivastava
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

7.  Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling.

Authors:  Oli Sarkar; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

8.  Inhibition of overexpression of Giα proteins and nitroxidative stress contribute to sodium nitroprusside-induced attenuation of high blood pressure in SHR.

Authors:  Ekhtear Hossain; Oli Sarkar; Yuan Li; Madhu B Anand-Srivastava
Journal:  Physiol Rep       Date:  2018-03

9.  Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression.

Authors:  Chris L Schaich; Megan Grabenauer; Brian F Thomas; Hossam A Shaltout; Patricia E Gallagher; Allyn C Howlett; Debra I Diz
Journal:  Front Physiol       Date:  2016-06-09       Impact factor: 4.566

10.  Dopaminergic Modulation of Goal-Directed Behavior in a Rodent Model of Attention-Deficit/Hyperactivity Disorder.

Authors:  Joman Y Natsheh; Michael W Shiflett
Journal:  Front Integr Neurosci       Date:  2018-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.